Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Effectiveness and Safety of OviTex® PRS in Breast Reconstruction

NCT: NCT07135596 · RECRUITING

NCT IDNCT07135596
StatusRECRUITING
Start Date2026-04-10
Completion2034-06

Brief Summary

The purpose of this study is to evaluate the safety and effectiveness of OviTex PRS in subjects undergoing implant-based breast reconstruction.

Frequently Asked Questions

What is Effectiveness and Safety of OviTex® PRS in Breast Reconstruction?

Effectiveness and Safety of OviTex® PRS in Breast Reconstruction is a clinical trial registered under NCT07135596. Current status: RECRUITING.

What is the status of NCT07135596?

The current status of NCT07135596 (Effectiveness and Safety of OviTex® PRS in Breast Reconstruction) is: RECRUITING.

When did Effectiveness and Safety of OviTex® PRS in Breast Reconstruction start?

Effectiveness and Safety of OviTex® PRS in Breast Reconstruction started on 2026-04-10.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑